Founders are turning to tech VCs to fund the riskiest stage of starting a drug company. It's testing the divide between the biotech and tech worlds. NewsRob MaguireMarch 2, 2022
https://www.biospace.com/article/bayer-poaches-gsk-s-christine-roth-editas-terminates-cmo-other-executive-moves NewsRob MaguireFebruary 8, 2022
CVS inks a deal with Medable to enroll more patients in clinical trials NewsRob MaguireFebruary 8, 2022
Al Sandrock notches another post-Biogen role — and it's taking him right back onto familiar ground NewsRob MaguireFebruary 8, 2022
Alfred W. Sandrock, Jr., M.D., Ph.D., Joins Verge Genomics’ Board of Directors NewsRob MaguireFebruary 8, 2022
Alice Zhang's 'all-in-human' AI and genomics upstart scores a $98M Series B NewsRob MaguireDecember 16, 2021
A very delicate balance Could blocking lysosomal gatekeeper PIKfyve slow neurodegeneration? NewsRob MaguireNovember 17, 2021
AUGMENTED INTELLIGENCE IN DRUG DISCOVERY XCHANGE WEST COAST 2021 SAN FRANCISCO NewsRob MaguireSeptember 21, 2021
Covid-19 Devastated Some Industries But Accelerated AI Use By Companies Across The Country NewsRob MaguireApril 5, 2021
Verge Genomics Announces the Addition of Steve Kanes to its Board of Directors NewsRob MaguireMarch 9, 2021
